Orencia

Medicinal product

(Invented) name

Orencia

Active substance (s)

Abataceptas

Strength

125 mg

Pharmaceutical form

injekcinis tirpalas užpildytame švirkštiklyje

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AA24, Abatacept

Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG, Airija

Date of authorisation

2007-05-21

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled pen	1 ml
Abataceptas	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
64679	79166	1079166	užpildytas švirkštiklis	N4 (ClickJect)		Receptinis	EU/1/07/389/011	Netiekiama	-	-	No	-	-
64680	79167	1079167	užpildytas švirkštiklis	N12 (3x4) (ClickJect su adatų apsaugomis)		Receptinis	EU/1/07/389/012	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2007-05-21	Registruotas